Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.
Can drug companies make drugs, AND money?
By
Nikhil Bhojwani
Biopharma
,
Payers
Read more
Boiling the Ocean…or not
By
Nikhil Bhojwani
Payers
,
Providers
,
Digital
,
Read more
MA hospital relative prices by payer
By
Nikhil Bhojwani
Payers
,
Providers
Read more
Staked out territory by Massachusetts hospital systems
By
Nikhil Bhojwani
Providers
Read more
Could the Employer Mandate lead to reduced coverage?
By
Nikhil Bhojwani
Payers
Read more
Ambidextrous strategy: PART 2 – Scenario Implications
By
Nikhil Bhojwani
Payers
,
Providers
Read more
Ambidextrous strategy: PART 1 – Payer and provider strategy for two very different worlds
By
Nikhil Bhojwani
Payers
,
Providers
Read more
Could a delay in the employer mandate be a boost to government run exchanges?
By
Nikhil Bhojwani
Payers
Read more
Readmissions rate fallacy
By
Nikhil Bhojwani
Providers
Read more
Emerging Unintended Consequences of Health Care Reform
By
Nikhil Bhojwani
Payers
,
Providers
Read more
Conventional wisdom that provider capacity drives cost questioned in new study
By
Nikhil Bhojwani
Providers
Read more
Surprising implication of drivers of Medicare FFS variation – MedPAC
